10X Genomics Inc vs DENTSPLY SIRONA Inc — how do they compare? 10X Genomics Inc trades at $46.82 (market cap $5.48B), while DENTSPLY SIRONA Inc trades at $13.56 (market cap $2.70B). The key difference: 10X Genomics Inc is far larger — about 2× DENTSPLY SIRONA Inc's market cap, and DENTSPLY SIRONA Inc pays a 5.04% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| TXG | XRAY | |
|---|---|---|
Market Cap | $5.48B | $2.70B |
Sector | Health | Health |
52-Week High | $45.80 | $16.85 |
52-Week Low | $11.34 | $9.64 |
Enterprise Value | $5.02B | $4.84B |
Dividend Yield | — | 5.04% |
Trailing returns across standard periods
Latest headlines on both assets
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →